Revenue,
USD 1.20 Bn
Forecast Year,
USD 2.71 Bn
CAGR, 2025 -
8.50%
Report Coverage
Worldwide
Yellow Fever Vaccines Market Size Analysis
Yellow Fever Vaccines Market Size By End User 2024 to 2034 (USD )
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Government/Institutional | 0.40 | 0.43 | 0.46 | 0.49 | 0.54 | 0.59 | 0.63 | 0.69 | 0.76 | 0.81 | 0.89 |
| Private/Travel Clinics | 0.40 | 0.42 | 0.46 | 0.50 | 0.52 | 0.56 | 0.60 | 0.65 | 0.71 | 0.77 | 0.84 |
| Hospitals | 0.40 | 0.45 | 0.50 | 0.55 | 0.60 | 0.65 | 0.72 | 0.79 | 0.84 | 0.91 | 0.99 |
Yellow Fever Vaccines Market Size By Age Group 2024 to 2034 (USD )
| Age Group | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pediatric | 0.60 | 0.65 | 0.72 | 0.78 | 0.84 | 0.91 | 0.99 | 1.07 | 1.15 | 1.25 | 1.36 |
| Adult | 0.60 | 0.65 | 0.70 | 0.75 | 0.82 | 0.90 | 0.97 | 1.06 | 1.16 | 1.25 | 1.35 |
Yellow Fever Vaccines Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.24 | 0.26 | 0.28 | 0.30 | 0.33 | 0.36 | 0.37 | 0.40 | 0.42 | 0.47 | 0.49 |
| Europe | 0.24 | 0.26 | 0.29 | 0.32 | 0.35 | 0.38 | 0.42 | 0.45 | 0.49 | 0.53 | 0.56 |
| Asia Pacific | 0.24 | 0.26 | 0.28 | 0.32 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.51 | 0.56 |
| Latin America | 0.24 | 0.26 | 0.28 | 0.29 | 0.31 | 0.35 | 0.39 | 0.42 | 0.47 | 0.51 | 0.56 |
| Middle East & Africa | 0.24 | 0.26 | 0.29 | 0.31 | 0.32 | 0.34 | 0.37 | 0.41 | 0.45 | 0.49 | 0.54 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com